Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults

OBJECTIVES: Studies have reported an association between serotonin reuptake inhibitors (SRIs) and accelerated bone loss. Genetic variation in the serotonin system might modulate bone metabolism changes during SRI treatment. In a clinical trial we examined functional genetic polymorphisms of serotoni...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: GARFIELD, LAUREN D., MÜLLER, DANIEL J., KENNEDY, JAMES L., MULSANT, BENOIT H., REYNOLDS, CHARLES F., TEITELBAUM, STEVEN L., CIVITELLI, ROBERTO, DIXON, DAVID, TODOROV, ALEXANDRE A., LENZE, ERIC J.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4097941/
https://ncbi.nlm.nih.gov/pubmed/24074042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/15622975.2013.832380
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items